Bacampicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8GM2J22278, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as bacampicillin, which bears US NIH Compound Identifier 39849. Bacampicillin most often comes in base and hydrochloride forms. European Medicines Agency schedules Bacampicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05666MIG. The term BACAMPICILLIN is an International Non-Proprietary Name. World Health Organization schedules bacampicillin in its Anatomical Therapeutic Chemical (ATC) Classification. BACAMPICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bacampicillin under HS 29411090 and SITC 54131. As of Q4 2014, BACAMPICILLIN remains the US FDA Preferred Term for this commodity. Bacampicillin bears US NLM identifiers UMLS ID C0052865 and NCI Concept Code C65245. SMILES: S1C2N(C(C1(C)C)C(=O)OC(OC(=O)OCC)C)C(=O)C2NC(=O)C(N)C1CCCCC1.